These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28343650)

  • 1. [Surveillance system on drug abuse: Interest of the French national OPPIDUM program of French addictovigilance network].
    Frauger E; Pochard L; Boucherie Q; Giocanti A; Chevallier C; Daveluy A; Gibaja V; Caous AS; Eiden C; Authier N; Le Boisselier R; Guerlais M; Jouanjus É; Lepelley M; Pizzoglio V; Pain S; Richard N; Micallef J;
    Therapie; 2017 Sep; 72(4):491-501. PubMed ID: 28343650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OPPIDUM surveillance program: 20 years of information on drug abuse in France.
    Frauger E; Moracchini C; Le Boisselier R; Braunstein D; Thirion X; Micallef J;
    Fundam Clin Pharmacol; 2013 Dec; 27(6):672-82. PubMed ID: 23510229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey.
    Nordmann S; Frauger E; Pauly V; Orléans V; Pradel V; Mallaret M; Thirion X; Micallef J
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):184-90. PubMed ID: 22109894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health].
    Micallef J; Jouanjus É; Mallaret M; Lapeyre Mestre M
    Therapie; 2019 Dec; 74(6):579-590. PubMed ID: 31694770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observation of psychoactive substance consumption: methods and results of the French OPPIDUM programme.
    Thirion X; Micallef J; Barrau K; Djezzar S; Sanmarco JL; Lagier G
    Eur Addict Res; 2001 Mar; 7(1):32-6. PubMed ID: 11316923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of addictive behaviours among new prisoners in France using the OPPIDUM program].
    Pauly V; Frauger E; Rouby F; Sirere S; Monier S; Paulet C; Gibaga V; Micallef J; Thirion X
    Encephale; 2010 Apr; 36(2):122-31. PubMed ID: 20434629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey.
    Frauger E; Nordmann S; Orleans V; Pradel V; Pauly V; Thirion X; Micallef J;
    Fundam Clin Pharmacol; 2012 Aug; 26(4):549-56. PubMed ID: 21564282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network].
    Modelon H; Frauger E; Laurenceau D; Thirion X; Mallaret M; Micallef J;
    Therapie; 2007; 62(4):337-46. PubMed ID: 17983559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of methadone and high dosage buprenorphine users in French care centres.
    Barrau K; Thirion X; Micallef J; Chuniaud-Louche C; Bellemin B; San Marco JL
    Addiction; 2001 Oct; 96(10):1433-41. PubMed ID: 11571062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow-release oral morphine sulfate abuse: results of the postmarketing surveillance systems for psychoactive prescription drug abuse in France.
    Peyriere H; Eiden C; Micallef J; Lapeyre-Mestre M; Faillie JL; Blayac JP
    Eur Addict Res; 2013; 19(5):235-44. PubMed ID: 23428846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Harm reduction centers ("CAARUD"): privileged places for warning signal detection in addictovigilance].
    Moracchini C; Frauger E; Pauly V; Nordmann S; Thirion X; Micallef J;
    Therapie; 2012; 67(5):437-45. PubMed ID: 23241253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France.
    Pochard L; Dupouy J; Frauger E; Giocanti A; Micallef J; Lapeyre-Mestre M;
    Fundam Clin Pharmacol; 2018 Apr; 32(2):188-197. PubMed ID: 29337399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey.
    Blayac L; Ponte C; Lavaud M; Micallef J; Lapeyre-Mestre M
    Therapie; 2023; 78(2):201-211. PubMed ID: 36283856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network.
    Frauger E; Pauly V; Pradel V; Rouby F; Arditti J; Thirion X; Lapeyre Mestre M; Micallef J
    Fundam Clin Pharmacol; 2011 Oct; 25(5):633-41. PubMed ID: 21077937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reimbursement of opiate substitution drugs to militaries in 2007].
    d'Argouges F; Desjeux G; Marsan P; Thevenin-Garron V
    Encephale; 2012 Sep; 38(4):304-9. PubMed ID: 22980471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of subjects under opiate maintenance treatment in primary care using the OPEMA data 2013].
    Gentile G; Frauger E; Giocanti A; Pauly V; Orleans V; Amaslidou D; Thirion X; Micallef J;
    Therapie; 2016 Jun; 71(3):307-13. PubMed ID: 27235654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM survey.
    Daveluy A; Frauger E; Peyrière H; Moracchini C; Haramburu F; Micallef J
    Fundam Clin Pharmacol; 2017 Feb; 31(1):126-131. PubMed ID: 27581837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction].
    Thirion X; Barrau K; Micallef J; Haramburu F; Lowenstein W; Sanmarco JL
    Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A10-7. PubMed ID: 10855372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022.
    Garnier C; Schein M; Lacroix C; Jouve E; Soeiro T; Gentile G; Lapeyre Mestre M; Micallef J
    CNS Drugs; 2024 Sep; 38(9):743-751. PubMed ID: 38990472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data.
    Roussin A; Soeiro T; Fouque C; Jouanjus E; Frauger E; Fouilhé N; Mallaret M; Micallef J; Lapeyre-Mestre M;
    Br J Clin Pharmacol; 2022 Aug; 88(8):3789-3802. PubMed ID: 35318713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.